No Data
No Data
Express News | EF Hutton Initiates Coverage On Imunon With Buy Rating, Announces Price Target of $29
IMUNON's Ovarian Cancer R&D Day to Feature Presentations From IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management
Imunon Files for Stock Resale by Security Holders
IMUNON to Host R&D Day on September 18th
Express News | HC Wainwright & Co. Reiterates Buy on Imunon, Maintains $14 Price Target
Imunon Analyst Ratings
No Data
No Data